Royals Pivot to Veteran Depth as India's Shoulder Ends Season

The Royals promoted veteran infielder Josh Rojas from Triple-A Omaha on Wednesday, filling a 40-man roster spot vacated by Jonathan India's move to the 60-day injured list. India's season-ending shoulder surgery—performed in April, roughly seven weeks ago—removes a projected regular from the middle infield and forces Kansas City's hand on how it structures its bench going forward.

India was expected to carry a meaningful workload when healthy; instead, the organization now turns to Rojas, a 32-year-old journeyman with 1,200+ major-league plate appearances across nine seasons. The swap reflects a calculated trade-off: concrete, low-variance depth over the speculative upside of keeping a slot open for a younger prospect. Rojas has averaged .265/.336/.406 over his career—league-average offensive output packaged in positional flexibility. He can play second, short, or third, which matters in a compressed bench where injuries compound leverage.

Stephen Kolek's simultaneous placement on the family medical emergency list opened the secondary pathway, but the primary driver is India's absence. A shoulder injury for an infielder isn't a soft tissue that heals in weeks; surgery in April signals at least a four-to-six-month recovery window, extending well into the postseason picture. The Royals' front office decided that gambling on India's health was costlier than anchoring bench production now.

For prop purposes, this move tightens the Royals' bench offensive floor but softens ceiling upside. Rojas will see 20–25% of the at-bats India would have claimed, but those plate appearances won't be neutral-value swings—they'll come in lower-leverage spots against right-handed pitchers or late-inning defensive substitutions. The Royals' team offensive total may face modest pressure if India was priced as a full-time contributor; markets likely already baked in some absence, but the certainty of a season-ending injury (rather than a short-term rehab window) removes the speculative recovery discount. Over the next two weeks, as the market fully processes India's removal, team totals should hold relatively steady or tick down marginally—the adjustment was already pricing in injury risk, just with a shorter timeline attached.